Sentence examples for label for patients from inspiring English sources

The drug is already approved as a treatment for kidney cancer, which means that doctors are allowed to prescribe it "off label" for patients with liver cancer.

Both medications were used at the doses recommended in the label for patients with severe RI.

In 2009, the FDA expanded the bosentan label for patients with functional class II on the basis of the EARLY (Endothelin Antagonist tRial in mildLY symptomatic pulmonary arterial hypertension patients) [ 29].

Specimens were immediately put in 10% formalin, appropriately labeled for patients name, gender, age and type of procedure/specimen and transferred to histopathology laboratory where a specific ID number was given to each specimen.

Several years ago, Kyashna-Tocha established the Evergreen State Cannabis Trade Alliance, which encouraged dispensary owners to submit marijuana for testing, and issued a label for "patient-ready" weed.

Let y i, j be the response (i.e. progression label) for patient i at time j, and let μ i, j be the expected value of y i, j.

National guidelines do recommend antipsychotics for the relatively rare condition of psychotic depression and as a possible intervention for treatment-resistant cases of severe depression 3 and OCD 4. In clinical practice, these agents may be prescribed 'off-label' for patients who do not have a diagnosis of SMI in their clinical notes.

Both drugs in this study were used at their expected maximal effective and recommended doses (in accordance with product labelling) for patients with severe RI.

We performed preliminary experiments to examine the oxidative capacity of five cell lines that showed different patterns on S-methionine pulse labelling for mitochondrial translation (Patients 9, 10, 12, 32, 36 and control cells).

Medical experts say the findings offer a rare glimpse of what happens in the real world of medical practice, when doctors prescribe drugs or treatments "off label" -- for patients who do not meet the criteria for which the drug agency approved the treatments.

A representative double-immunofluorescent labeling for patient's serum and RT97 antibodies, an axonal marker, confirmed the AAbs specificity for neuronal axons (Fig. 6).